NCT03101358
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1|Phase 2
Drug Category: Chemotherapy
Key Eligibility Criteria:
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Skin
Additional Notes:
Exclusions:
https://ClinicalTrials.gov/show/NCT03101358